Brazilian health regulator Anvisa AstraZeneca China Sinovac Biotech Ltd COVID 19 vaccines Russia Sputnik V

URL copied
Brazil says no to Russia's Sputnik V
The Brazil National Health Surveillance Agency (Anvisa)  declined the request to approve the Russian-developed Sputnik V vaccine against COVID-19 for emergency use in Brazil. While, emergency use of COVID-19 vaccines from China’s Sinovac Biotech Ltd and Britain’s AstraZeneca have been approved by the regulator. 
Citing the agency, TASS reported that the request does not comply with the minimal criteria for this task.
"The request was returned to Uniao Quimica, because it does not comply with the minimal criteria in particular, due to lack of permission for third phase of clinical trials, as well as in regards to issue dealing with the advanced production methods," TASS quoted the Anivsa.

Related Keywords

Russia ,Brazil ,Russian ,Uniao Quimica ,Russian Fund ,China Sinovac Biotech Ltd ,Brazil National Health Surveillance Agency Anvisa ,Russian Direct Investment Fund ,Image Source ,Brazil National Health Surveillance Agency ,Sinovac Biotech Ltd ,Brazilian Health Regulator ,Anvisa ,Astrazeneca ,Chinese Vaccine ,Covid 19 Vaccines ,Sputnik V ,Astrazeneca Vaccine ,Chinese Covid 19 Vaccine ,Chinese Coronavirus Vaccine ,Brazil Vaccine ,Brazil Coronavirus Vaccine , ,ரஷ்யா ,பிரேசில் ,ரஷ்ய ,ஊனியஓ குவிமிகா ,ரஷ்ய நிதி ,ரஷ்ய நேரடி முதலீடு நிதி ,படம் மூல ,பிரேசிலியன் ஆரோக்கியம் சீராக்கி ,அன்விசை ,சீன தடுப்பூசி ,ஸ்பட்நிக் வ் ,பிரேசில் தடுப்பூசி ,